Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
265
datasets available to search
ShareScore release 0.9.0
Dataset results
265 results for “Aromatase inhibitors”
Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
ClinicalTrials.gov study NCT05637671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
ClinicalTrials.gov study NCT01814865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Pr
ClinicalTrials.gov study NCT05801705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors
ClinicalTrials.gov study NCT03712813. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms
ClinicalTrials.gov study NCT02874222. IPD Sharing: YES. Countries: 1. Publications: 0.
Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
ClinicalTrials.gov study NCT01693731. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00687648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors
ClinicalTrials.gov study NCT05628077. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Frac
ClinicalTrials.gov study NCT00767585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)
ClinicalTrials.gov study NCT00973505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Feasibility Study of Topical Cannabinoids for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in Adults With Hormone Receptor-Positive Breast Cancer (CanAroma)
ClinicalTrials.gov study NCT05935891. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors
ClinicalTrials.gov study NCT03096041. IPD Sharing: NO. Countries: 1. Publications: 0.
Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer
ClinicalTrials.gov study NCT05569187. IPD Sharing: NO. Countries: 1. Publications: 0.
10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)
ClinicalTrials.gov study NCT00885612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
ClinicalTrials.gov study NCT04227327. IPD Sharing: NO. Countries: 1. Publications: 0.
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects
ClinicalTrials.gov study NCT00497458. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT06401889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: Higher insulin resistance & adiposity in post-menopausal women with breast cancer treated with aromatase inhibitors
Open the record for dataset details and reuse information.
Transcriptome of juvenile zebrafish treated with the aromatase inhibitor exemestane and solvent control
GEO Series GSE142353. Danio rerio. 6 samples. Type: Expression profiling by high throughput sequencing.
Effect of aromatase inhibitor (AI) treatment on gene expression of breast cancer [tissueseq]
GEO Series GSE206199. Homo sapiens. 14 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.